Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Technology, Method, Test Type, Pathogen, and End User

Description

List of Tables

The global sepsis diagnostics market is projected to reach US$ 1,226.52 million by 2028 from US$ 661.83 million in 2021; it is expected to grow at a CAGR of 9.2% from 2021 to 2028. Factors such as the rising incidence of sepsis due to increasing nosocomial infections and growing demand for rapid diagnostic tests leading to increasing product launches drive the overall growth of the sepsis diagnostics market. However, the lack of skilled professionals hampers the sepsis diagnostics market growth.

Sepsis is the body's extreme response to an infection. Sepsis is a serious clinical condition that can be a result of other infections, including viral infections, such as COVID-19 or influenza. It is a life-threatening medical emergency. Early detection and specific clinical intervention are crucial for improving the outcome of patients suffering from sepsis. Sepsis caused by bacteria involves cascade of reactions, such as lack of oxygen supply to cells and inactivation of immune complexes involved in the clearance of bacteria and its particles, which progresses to multiple organ failure. Sepsis is considered as a three staged syndrome by many physicians that starts with sepsis, leading to severe sepsis, and results in septic shock, which is considered as a medical emergency. Sepsis has a high mortality and morbidity rate. Sepsis diagnostics is the study of diagnosis of sepsis, which is a serious clinical condition that generally results from primary bacterial infection or, less frequently, from a fungal and/or viral infection. According to an article published by the National Center for Biotechnology Information in February 2019, the mortality rate of sepsis is 25 % to 30 %.

Most of the diagnostic tests for sepsis are time-consuming and take up to 72 hours to provide results. In the era of molecular diagnosis for every kind of disease, the demand for rapid diagnostic tests for sepsis is rising. As a result, many key players operating in the industry put efforts into developing innovative rapid diagnostic tests for sepsis. For instance, in September 2020, Barcelona-based Loop Diagnostics launched a point-of-care diagnosis platform. The platform replaces the traditional methods of blood culture analysis and provide rapid results. Also, it can identify bacterial infections via blood-based markers and provide test results in two hours with a 99% accuracy rate. Additionally, in May 2020, Beckman Coulter launched its new DxH 690T hematology analyzer with early sepsis indicators in the US.

Moreover, the key players developed cost-effective diagnostic tests to overcome all the challenges associated with sepsis diagnosis. For instance, Inflammatix, a pioneering molecular diagnostics company, published a health economic model that shows the use of the company's HostDxTM Sepsis test is cost-effective as compare to standard methods. The test was performed on patients suspected of acute respiratory tract infections (ARTI) in Emergency Departments. The study was published in April 2020 in The Journal of Health Economics and Outcomes Research. The model informed hospital clinicians of the potential clinical and economic benefits of widespread adoption of the HostDx Sepsis test.

Furthermore, the rising need for rapid diagnostics for sepsis fueled the research activities among key players in recent years. Both the existing players and the start-ups in sepsis diagnostics are well supported financially by government and research organizations. For instance, in April 2020, Cytovale Inc. partnered with the Biomedical Advanced Research and Development Authority (BARDA) for sepsis diagnosis in patients with respiratory infections, including COVID-19. The research was estimated to stand at US$ 5.9 million, with a contribution of approximately US$ 3.83 million by BARDA. Thus, the launch of effective treatments and ongoing clinical trials would provide lucrative opportunities for the sepsis diagnostics market during the forecast period.

The global sepsis diagnostics market is segmented on the basis of product, technology, method, test type, pathogen, and end user. Based on product, the sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment is estimated to account for the largest market share during 2021-2028. According to the Journal of the Academy of Clinical Microbiologists report, blood culture media remains one of the most critical investigations in the sepsis management as it allows identification of the responsible organism for sepsis, appropriate choice of empirical and specific antibiotics, and points toward further investigations for identifying the focus on infection. A blood culture media is recommended for all septic patients. Automation in the blood culture system has enabled maximum yield of pathogens in the shortest possible time to improve patient management and save lives. The method is highly recommended as it reveals one of the highest levels of evidence in the diagnostic workup of a sepsis patient. Such aforementioned factors support the market growth for the blood culture media segment and ultimately fuel the growth of sepsis diagnostics market.

The software segment is expected to register the highest CAGR for the overall sepsis diagnostics market during the forecast period. Several top players involved in the global sepsis diagnostics market continuously launch different software to stay forefront in the market. For instance, Mobile Technology announced the launch of Nerve center Software that play an important role in early detection of sepsis and other life-threatening conditions among patients. The new software uses vital signs and pathology results for automating the early diagnosis of sepsis and then ensures that the appropriate doctors and nurses are immediately alerted on their mobile devices when a risk of sepsis has been identified.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Library of Medicine, and National Center for Biotechnology Information (NCBI) are among the primary and secondary sources referred to while preparing the report on the global sepsis diagnostics market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the sepsis diagnostics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: TIPHE100001391

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Sepsis Diagnostics Market - By Product
- 1.3.2 Global Sepsis Diagnostics Market - By Technology
- 1.3.3 Global Sepsis Diagnostics Market - By Method
- 1.3.4 Global Sepsis Diagnostics Market - By Test Type
- 1.3.5 Global Sepsis Diagnostics Market - By Pathogen
- 1.3.6 Global Sepsis Diagnostics Market - By End User
- 1.3.7 Global Sepsis Diagnostics Market - By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Sepsis Diagnostics Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East & Africa PEST Analysis
- 4.2.5 South & Central America PEST Analysis
4.3 Experts Opinion

5. Sepsis Diagnostics Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
- 5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
5.2 Market Restraints
- 5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
- 5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research
5.4 Future Trends
- 5.4.1 Rising Technological Advancements in Sepsis Diagnosis
5.5 Impact Analysis

6. Sepsis Diagnostics Market- Global Analysis

6.1 Global Sepsis Diagnostics Market Revenue Forecast and Analysis
- 6.1.1 Global Sepsis Diagnostics Market Revenue Forecast and Analysis
- 6.1.2 Market Positioning of Key Players
- 6.1.3 Global Sepsis Diagnostics market - Market Potential Analysis, By Region
6.2 Comparative Company Analysis
- 6.2.1 Growth Strategy Analysis
- 6.2.2 Performance of Key Players
  - 6.2.2.1 BioMerieux, Inc.
  - 6.2.2.2 Danaher
- 6.2.3 Market Share Analysis of Sepsis Diagnostics Market

7. Global Sepsis Diagnostics Market Revenue and Forecasts To 2028- by Product

7.1 Overview
7.2 Global Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
7.3 Instruments
- 7.3.1 Overview
- 7.3.2 Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Reagents and Assays
- 7.4.1 Overview
- 7.4.2 Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Blood Culture Media
- 7.5.1 Overview
- 7.5.2 Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Software
- 7.6.1 Overview
- 7.6.2 Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Technology

8.1 Overview
8.2 Global Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
8.3 Molecular Diagnostics
- 8.3.1 Overview
- 8.3.2 Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.1 Polymerase Chain Reaction
    - 8.3.2.1.1 Overview
    - 8.3.2.1.2 Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
    - 8.3.2.2.1 Overview
    - 8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.3 Syndromic Panel-Based Testing
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.4 Microarrays
    - 8.3.2.4.1 Overview
    - 8.3.2.4.2 Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Flow Cytometry
- 8.4.1 Overview
- 8.4.2 Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.3 Real-Time Cell Analysis
  - 8.4.3.1 TaqMan-Based Multiplex RT PCR and Blood Culture
    - 8.4.3.1.1 Characteristics of TaqMan Assays
  - 8.4.3.2 Magicplex (TM)Sepsis Real-Time Tests Performed in Tertiary Regina Margherita Children's Hospital (Turin, Italy) - Case Study
    - 8.4.3.2.1 Abstract
    - 8.4.3.2.2 Conclusion:
  - 8.4.3.3 Companies that are engaged in providing Sepsis Diagnostic solutions
  - 8.4.3.4 Sepsis diagnosis by real-time PCR
  - 8.4.3.5 New next-generation sequencing technique and technological advancements/innovations
  - 8.4.3.6 Real Time Cellular Analysis Using Impedance Measurements
- 8.4.4 Real-Time Cell Analysis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Microfluidics
- 8.5.1 Overview
- 8.5.2 Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Immunoassay
- 8.6.1 Overview
- 8.6.2 Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Biomarkers
- 8.7.1 Overview
- 8.7.2 Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
- 8.7.3 Metabolomics
  - 8.7.3.1 Metabolite Profile in Sepsis
  - 8.7.3.2 Penetration/Usage Pattern of Metabolomics in Sepsis Diagnosis
  - 8.7.3.3 Early Prediction of Sepsis by Metabolite Profiling
  - 8.7.3.4 Future Role of Omics in Diagnosis and Therapy of Sepsis
    - 8.7.3.4.1 Genomics
    - 8.7.3.4.2 Proteomics
  - 8.7.3.5 Sepsis Biomarkers and Diagnostic Tools
  - 8.7.3.6 Role Metabolomics and Proteomics in Sepsis
  - 8.7.3.7 Potential Approach for Identifying Small Molecule Biomarkers for Acute Kidney Disease Prognosis
  - 8.7.3.8 Recent Application of Metabolomics in Sepsis Diagnosis
  - 8.7.3.9 Metabolics in Mitochondrial Function
  - 8.7.3.10 Substantial Potential of Metabolomics in Diagnostics for Mitochondrial Medicine
- 8.7.4 Metabolomics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Microbiology
- 8.8.1 Overview
- 8.8.2 Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Method

9.1 Overview
9.2 Global Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
9.3 Automated Diagnostics
- 9.3.1 Overview
- 9.3.2 Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Conventional Diagnostics
- 9.4.1 Overview
- 9.4.2 Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Test Type

10.1 Overview
10.2 Global Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
10.3 Point-of-Care Tests
- 10.3.1 Overview
- 10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4 Laboratory Tests
- 10.4.1 Overview
- 10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - Pathogen

11.1 Overview
11.2 Global Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
11.3 Bacterial Sepsis
- 11.3.1 Overview
- 11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.4 Fungal Sepsis
- 11.4.1 Overview
- 11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
- 11.5.1 Overview
- 11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12. Sepsis Diagnostics Market Revenue and Forecasts To 2028 - End User

12.1 Overview
12.2 Global Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
12.3 Hospitals
- 12.3.1 Overview
- 12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.4 Pathology and Reference Laboratories
- 12.4.1 Overview
- 12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.5 Others
- 12.5.1 Overview
- 12.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13. Global Sepsis Diagnostics Market Revenue and Forecasts to 2028 - Geographical Analysis

13.1 North America: Sepsis Diagnostics Market
- 13.1.1 Overview
- 13.1.2 North America: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 13.1.3 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
- 13.1.4 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  - 13.1.4.1 Biomarkers: Metabolomics 2019-2028
  - 13.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
  - 13.1.4.3 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
- 13.1.5 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
- 13.1.6 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
- 13.1.7 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
- 13.1.8 North America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
- 13.1.9 North America: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
  - 13.1.9.1 US: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.9.1.1 Overview
    - 13.1.9.1.2 US: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.9.1.3 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.1.9.1.4 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.1.9.1.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.1.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.1.9.1.4.3 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.1.9.1.5 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.1.9.1.6 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.1.9.1.7 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.1.9.1.8 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  - 13.1.9.2 Canada: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.9.2.1 Overview
    - 13.1.9.2.2 Canada: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.9.2.3 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.1.9.2.4 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.1.9.2.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.1.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.1.9.2.4.3 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.1.9.2.5 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.1.9.2.6 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.1.9.2.7 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.1.9.2.8 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
  - 13.1.9.3 Mexico: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.9.3.1 Overview
    - 13.1.9.3.2 Mexico: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.1.9.3.3 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.1.9.3.4 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.1.9.3.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.1.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.1.9.3.4.3 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.1.9.3.5 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.1.9.3.6 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.1.9.3.7 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.1.9.3.8 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
13.2 Europe: Sepsis Diagnostics Market
- 13.2.1 Overview
- 13.2.2 Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 13.2.3 Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
- 13.2.4 Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
  - 13.2.4.1 Biomarkers: Metabolomics 2019-2028
  - 13.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
  - 13.2.4.3 Europe: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
- 13.2.5 Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
- 13.2.6 Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
- 13.2.7 Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
- 13.2.8 Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- 13.2.9 Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
  - 13.2.9.1 Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.1.1 Overview
    - 13.2.9.1.2 Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.1.3 Germany: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.1.4 Germany: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.1.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.2.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.2.9.1.4.3 Germany: Sepsis Diagnostics Market, by Molecular diagnostics- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.1.5 Germany: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.1.6 Germany: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.1.7 Germany: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.1.8 Germany: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 13.2.9.2 France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.2.1 Overview
    - 13.2.9.2.2 France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.2.3 France: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.2.4 France: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.2.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.2.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.2.9.2.4.3 France: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.2.5 France: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.2.6 France: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.2.7 France: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.2.8 France: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 13.2.9.3 UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.3.1 Overview
    - 13.2.9.3.2 UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.3.3 UK: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.3.4 UK: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.3.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.2.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.2.9.3.4.3 UK: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.3.5 UK: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.3.6 UK: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.3.7 UK: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.3.8 UK: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 13.2.9.4 Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.4.1 Overview
    - 13.2.9.4.2 Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.4.3 Italy: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.4.4 Italy: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.4.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.2.9.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.2.9.4.4.3 Italy: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.4.5 Italy: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.4.6 Italy: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.4.7 Italy: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.4.8 Italy: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 13.2.9.5 Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.5.1 Overview
    - 13.2.9.5.2 Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.5.3 Spain: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.5.4 Spain: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.5.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.2.9.5.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.2.9.5.4.3 Spain: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.5.5 Spain: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.5.6 Spain: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.5.7 Spain: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.5.8 Spain: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 13.2.9.6 Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.6.1 Overview
    - 13.2.9.6.2 Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.6.3 Rest of Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.6.4 Rest of Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.6.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.2.9.6.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.2.9.6.4.3 Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.6.5 Rest of Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.6.6 Rest of Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.6.7 Rest of Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
    - 13.2.9.6.8 Rest of Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
13.3 Asia Pacific: Sepsis Diagnostics Market
- 13.3.1 Overview
- 13.3.2 Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
- 13.3.3 Asia Pacific: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
- 13.3.4 Asia Pacific: Sepsis Diagnostics Market, by Technology, 2019-2028 (USD Million)
  - 13.3.4.1 Biomarkers: Metabolomics 2019-2028
  - 13.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
  - 13.3.4.3 Asia Pacific Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
- 13.3.5 Asia Pacific: Sepsis Diagnostics Market, by Method, 2019-2028 (USD Million)
- 13.3.6 Asia Pacific: Sepsis Diagnostics Market, by Test Type, 2019-2028 (USD Million)
- 13.3.7 Asia Pacific: Sepsis Diagnostics Market, by Pathogen, 2019-2028 (USD Million)
- 13.3.8 Asia Pacific: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
- 13.3.9 Asia Pacific: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
  - 13.3.9.1 China: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.1.1 China: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.1.2 China: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
    - 13.3.9.1.3 China: Sepsis Diagnostics Market, by Technology, 2019-2028 (USD Million)
    - 13.3.9.1.3.1 Biomarkers: Metabolomics 2019-2028
    - 13.3.9.1.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.3.9.1.3.3 China Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.1.4 China: Sepsis Diagnostics Market, by Method, 2019-2028 (USD Million)
    - 13.3.9.1.5 China: Sepsis Diagnostics Market, by Test Type, 2019-2028 (USD Million)
    - 13.3.9.1.6 China: Sepsis Diagnostics Market, by Pathogen, 2019-2028 (USD Million)
    - 13.3.9.1.7 China: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
  - 13.3.9.2 Japan: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.2.1 Japan: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.2.2 Japan: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
    - 13.3.9.2.3 Japan: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
    - 13.3.9.2.3.1 Biomarkers: Metabolomics 2019-2028
    - 13.3.9.2.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.3.9.2.3.3 Japan Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.2.4 Japan: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
    - 13.3.9.2.5 Japan: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
    - 13.3.9.2.6 Japan: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
    - 13.3.9.2.7 Japan: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
  - 13.3.9.3 India: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.3.1 India: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.3.2 India: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
    - 13.3.9.3.3 India: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
    - 13.3.9.3.3.1 Biomarkers: Metabolomics 2019-2028
    - 13.3.9.3.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.3.9.3.3.3 India Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.3.4 India: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
    - 13.3.9.3.5 India: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
    - 13.3.9.3.6 India: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
    - 13.3.9.3.7 India: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
  - 13.3.9.4 Australia: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.4.1 Australia: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.4.2 Australia: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
    - 13.3.9.4.3 Australia: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
    - 13.3.9.4.3.1 Biomarkers: Metabolomics 2019-2028
    - 13.3.9.4.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.3.9.4.3.3 Australia Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.4.4 Australia: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
    - 13.3.9.4.5 Australia: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
    - 13.3.9.4.6 Australia: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
    - 13.3.9.4.7 Australia: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
  - 13.3.9.5 South Korea: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.5.1 South Korea: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.5.2 South Korea: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
    - 13.3.9.5.3 South Korea: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
    - 13.3.9.5.3.1 Biomarkers: Metabolomics 2019-2028
    - 13.3.9.5.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.3.9.5.3.3 South Korea Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.5.4 South Korea: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
    - 13.3.9.5.5 South Korea: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
    - 13.3.9.5.6 South Korea: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
    - 13.3.9.5.7 South Korea: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
  - 13.3.9.6 Rest of Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.6.1 Rest of Asia Pacific: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.6.2 Rest of Asia Pacific: Sepsis Diagnostics Market, By Product, 2019-2028 (USD Million)
    - 13.3.9.6.3 Rest of Asia Pacific: Sepsis Diagnostics Market, By Technology, 2019-2028 (USD Million)
    - 13.3.9.6.3.1 Biomarkers: Metabolomics 2019-2028
    - 13.3.9.6.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.3.9.6.3.3 Rest of APAC Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (USD Million)
    - 13.3.9.6.4 Rest of Asia Pacific: Sepsis Diagnostics Market, By Method, 2019-2028 (USD Million)
    - 13.3.9.6.5 Rest of Asia Pacific: Sepsis Diagnostics Market, By Test Type, 2019-2028 (USD Million)
    - 13.3.9.6.6 Rest of Asia Pacific: Sepsis Diagnostics Market, By Pathogen, 2019-2028 (USD Million)
    - 13.3.9.6.7 Rest of Asia Pacific: Sepsis Diagnostics Market, By End User, 2019-2028 (USD Million)
13.4 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts To 2028
- 13.4.1 Overview
- 13.4.2 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
- 13.4.3 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
- 13.4.4 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  - 13.4.4.1 Biomarkers: Metabolomics 2019-2028
  - 13.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
  - 13.4.4.3 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
- 13.4.5 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
- 13.4.6 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
- 13.4.7 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
- 13.4.8 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
- 13.4.9 Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
  - 13.4.9.1 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.4.9.1.1 Overview
    - 13.4.9.1.2 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.4.9.1.3 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.4.9.1.4 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.4.9.1.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.4.9.1.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.4.9.1.4.3 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.4.9.1.5 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.4.9.1.6 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.4.9.1.7 UAE: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.4.9.1.8 UAE: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  - 13.4.9.2 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.4.9.2.1 Overview
    - 13.4.9.2.2 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.4.9.2.3 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.4.9.2.4 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.4.9.2.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.4.9.2.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.4.9.2.4.3 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.4.9.2.5 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.4.9.2.6 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.4.9.2.7 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.4.9.2.8 Saudi Arabia: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  - 13.4.9.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.4.9.3.1 Overview
    - 13.4.9.3.2 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.4.9.3.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.4.9.3.4 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.4.9.3.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.4.9.3.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.4.9.3.4.3 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.4.9.3.5 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.4.9.3.6 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.4.9.3.7 South Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.4.9.3.8 South Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
  - 13.4.9.4 Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.4.9.4.1 Overview
    - 13.4.9.4.2 Rest of Middle East and Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.4.9.4.3 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
    - 13.4.9.4.4 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    - 13.4.9.4.4.1 Biomarkers: Metabolomics 2019-2028
    - 13.4.9.4.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
    - 13.4.9.4.4.3 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
    - 13.4.9.4.5 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 13.4.9.4.6 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
    - 13.4.9.4.7 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
    - 13.4.9.4.8 Rest of Middle East & Africa: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.5 South & Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028
- 13.5.1 Overview
- 13.5.2 South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
- 13.5.3 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
- 13.5.4 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  - 13.5.4.1 Biomarkers: Metabolomics 2019-2028
  - 13.5.4.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028
  - 13.5.4.3 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
- 13.5.5 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
- 13.5.6 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
- 13.5.7 South & Central America: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
- 13.5.8 South & Central America: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
- 13.5.9 South & Central America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
  - 13.5.9.1 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.5.9.1.1 Overview
    - 13.5.9.1.2 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
    - 13.5.9.1.3 Brazil: Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)
- 13.5.9